Novel challenges associated with novel agents: the evolving scenario in renal cell carcinoma

被引：0
|
作者：
Di Lorenzo, Giuseppe [1 ]
Buonerba, Carlo [1 ]
机构：
[1] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Oncol Med, Naples, Italy
来源：
FUTURE ONCOLOGY | 2016年 / 12卷 / 03期
关键词：
cabozantinib; immunotherapy; kidney cancer; nivolumab; targeted therapy; PROSTATE-CANCER; PHASE-3; TRIAL; SIPULEUCEL-T; EVEROLIMUS; IMMUNOTHERAPY; NIVOLUMAB;
D O I：
10.2217/fon.15.328
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 279
页数：3
相关论文
共 50 条
  • [21] A novel inflammation-associated prognostic signature for clear cell renal cell carcinoma
    Liu, Gangcheng
    Xiong, Donglan
    Che, Zhifei
    Chen, Hualei
    Jin, Wenyi
    ONCOLOGY LETTERS, 2022, 24 (03)
  • [22] The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma
    Ayuso, Carmen
    Bruix, Jordi
    HEPATOLOGY INTERNATIONAL, 2014, 8 (01) : 4 - 6
  • [23] The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma
    Carmen Ayuso
    Jordi Bruix
    Hepatology International, 2014, 8 : 4 - 6
  • [24] A novel case of hereditary leiomyomatosis- associated renal cell carcinoma with metastasis to
    Palma, Catalina A.
    Watson, Geoffrey
    Earls, Peter
    Patanjali, Nitya
    Laurence, Jerome
    Leslie, Scott
    UROLOGY CASE REPORTS, 2022, 45
  • [25] Novel candidate gene associated with mTOR inhibitor response in Renal Cell Carcinoma
    Roldan-Romero, J.
    Santos-Romero, M.
    Maroto, J.
    Anguera, G.
    Algaba, F.
    Ruiz-Llorente, S.
    Montero-Conde, C.
    Cascon, A.
    Roncador, G.
    Djouder, N.
    Robledo, M.
    Rodriguez-Antona, C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 561 - 561
  • [26] NOVEL CANDIDATE GENE ASSOCIATED WITH MTOR INHIBITOR RESPONSE IN RENAL CELL CARCINOMA
    Roldan-Romero, J. M.
    Santos-Romero, M.
    Maroto, J.
    Anguera, G.
    Algaba, F.
    Ruiz-Llorente, S.
    Montero-Conde, C.
    Cascon, A.
    Roncador, G.
    Djouder, N.
    Robledo, M.
    Rodriguez-Antona, C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 87 - 88
  • [27] Novel immunotherapy in metastatic renal cell carcinoma
    Cho, Yang Hyun
    Kim, Myung Soo
    Chung, Ho Seok
    Hwang, Eu Chang
    INVESTIGATIVE AND CLINICAL UROLOGY, 2017, 58 (04) : 220 - 227
  • [28] Cabozantinib as a Novel Therapy for Renal Cell Carcinoma
    Ulka Vaishampayan
    Current Oncology Reports, 2013, 15 : 76 - 82
  • [29] Novel therapies for renal cell carcinoma - an update
    Fishman, M
    Antonia, S
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (04) : 593 - 609
  • [30] Novel Therapies in Advanced Renal Cell Carcinoma
    Ivanyi, P.
    Winkler, T.
    Ganser, A.
    Reuter, C.
    Gruenwald, V
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2008, 105 (13): : 232 - U15
12345